Revolution Medicines Inc.
RVMD | NASDAQ
$189.85
-$1.46 (-0.76%)
Nov 2, 2026, 3:16 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -13.39 | -12.22 | -7.43 | -7.73 | -10.19 | -24.44 |
PEG Ratio | -0.20 | 1.68 | -0.29 | -0.31 | -0.19 | -1.03 |
PS Ratio | n/a | n/a | 280.24 | 54.28 | 62.35 | 61.34 |
PB Ratio | 9.28 | 3.24 | 1.78 | 2.80 | 3.04 | 5.55 |
P/FCF Ratio | -16.57 | -12.92 | -9.06 | -8.16 | -11.92 | -25.60 |
P/OCF Ratio | -16.87 | -13.16 | -9.26 | -8.56 | -12.45 | -26.35 |
OCF/S Ratio | n/a | n/a | -3.03K | -634.26 | -500.78 | -232.80 |
Debt / Equity Ratio | 0.10 | 0.06 | 0.05 | 0.09 | 0.11 | 0.07 |
Quick Ratio | 7.14 | 14.20 | 13.06 | 10.65 | 9.77 | 9.63 |
Current Ratio | 7.14 | 14.20 | 13.06 | 10.65 | 9.77 | 9.63 |
Asset Turnover | n/a | n/a | 0.01 | 0.04 | 0.04 | 0.08 |
Interest Coverage | -48.80 | n/a | -1.61K | n/a | -15.67K | -1.56K |
Return on Equity | -69.35% | -26.49% | -23.89% | -36.30% | -31.05% | -22.79% |
Return on Assets | -48.05% | -23.46% | -21.17% | -30.63% | -25.35% | -19.06% |
Return on Invested Capital | -56.83% | -28.61% | -25.10% | -34.07% | -27.49% | -21.06% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 100% | 100% | 100% | 100% |
Net Profit Margin | n/a | n/a | -3.77K% | -702.95% | -636.58% | -251.63% |
Pretax Profit Margin | n/a | n/a | -3.8K% | -704.14% | -636.58% | -252.50% |
Operating Profit Margin | n/a | n/a | -4.21K% | -730.01% | -639.70% | -257.54% |
FCF Margin | n/a | n/a | -3.09K% | -664.83% | -522.99% | -239.62% |
EBITDA Margin | n/a | n/a | -3.72K% | -676.85% | -611.59% | -237.10% |
Add to Watchlist
Select watchlists to add or remove RVMD